Welcome to Elvikon
At Elvikon, we are dedicated to transforming cutting-edge research into impactful solutions that serve industry and society alike. Headquartered in Stockholm, Sweden, with an R&D unit in Hyderabad, India, Elvikon is a growing force in the fields of Biotech, Pharma, Food, Medical Devices, and Energy, with a strong focus on Deep Tech innovations.
Our operations are built on two complementary pillars: world-class Contract Research Services (CRO) and the manufacturing of high-performance products, including our flagship silica gel for chromatography.
We offer end-to-end Research Services tailored to accelerate innovation and deliver tangible results. Whether you're a startup, SME, or a large enterprise, our CRO model provides cost-effective, flexible, and high-quality R&D support across multiple domains.
Beyond services, Elvikon also develops and supplies high-quality Silica Gel tailored for analytical and preparative chromatography applications. Designed to meet the demanding needs of laboratories and industrial users, our silica gel offers consistent performance, high surface area, and customizable particle sizes.
With a presence in Hyderabad and Stockholm, Elvikon is your global partner for scientific excellence, innovation, and product reliability.
🚀 Big News from Elvikon! We’re Now in Stockholm!
We’re thrilled to announce the opening of Elvikon AB, our new office in Stockholm, Sweden! This strategic expansion marks a key milestone in our mission to bring cutting-edge engineering solutions closer to our Nordic clients.
— 1st May 2025
🎉 Exciting Milestone for Elvikon!
We are thrilled to announce that Elvikon has received its first orderof Preparative Chromatography Silica Gel— a 10 kg batchmarking our entry into the market!
This is a significant step forward in our journey to deliver high-quality chromatographic solutions to the scientific and industrial communities.
A big thank you to our team, partners, and early adopters who believe in our technology and vision. Here's to many more milestones ahead!
— 30th April 2025
Copyright © All Rights Reserved
